DR ACKERMANS
Turnover is estimated at about €180,000, probably between €140,000 and €230,000. The micro format does not state turnover.
Balance sheet
balance sheet total €94,889 on 31-12-2025in euro
in euro
Position in the sector
11.6%
Higher than 15% of the 21,368 companies filing micro accounts in human health (NACE 86) in 2025.
0.95
Higher than 17% of the 20,917 companies filing micro accounts in human health (NACE 86) in 2025.
61.0%
Higher than 88% of the 21,218 companies filing micro accounts in human health (NACE 86) in 2025.
Net result: middle half · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 20222 months |
|---|---|---|---|---|---|
| 81,230 | 57,065 | 54,699 | 12,010 | ||
| 66,486 | 43,554 | 44,069 | 9,085 | ||
| 0 | 0 | 2,730 | 39,794 | ||
| -9,465 | 20,940 | 31,570 | - | ||
| -4,003 | 11,637 | 29,066 | -28,475 | ||
| 11.6% | 23.0% | 52.3% | 18.9% | ||
| 0.95 | 1.16 | 2.10 | 0.40 | ||
| 7.61 | 3.36 | 0.91 | 4.29 | ||
| 525.4% | 140.9% | 76.5% | 68.2% | ||
| 61.0% | 32.3% | 40.0% | 12.9% | ||
| over 100 | 66.56 | 46.43 | over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 20222 months |
|---|---|---|---|---|---|
| Balance sheet: assets | |||||
20/58 |
94,889 | 108,020 | 89,538 | 58,289 | |
21/28 |
16,798 | 25,376 | 33,994 | 39,497 | |
22/27 |
16,798 | 25,376 | 33,994 | 39,497 | |
23 |
1,478 | 2,024 | 2,570 | - | |
24 |
15,321 | 23,352 | 31,424 | 39,497 | |
29/58 |
78,090 | 82,644 | 55,544 | 18,792 | |
40/41 |
15,083 | 8,185 | 673 | 174 | |
40 |
15,083 | 8,185 | 673 | 174 | |
54/58 |
58,389 | 67,854 | 46,914 | 15,344 | |
490/1 |
4,618 | 6,605 | 7,957 | 3,274 | |
| Balance sheet: equity and liabilities | |||||
10/49 |
94,889 | 108,020 | 89,538 | 58,289 | |
10/15 |
11,022 | 24,795 | 46,859 | 11,022 | |
10/11 |
3,500 | 3,500 | 3,500 | 3,500 | |
13 |
7,522 | 7,522 | 7,522 | 7,522 | |
133 |
7,522 | 7,522 | 7,522 | 7,522 | |
14 |
0 | 13,773 | 35,837 | - | |
17/49 |
83,866 | 83,225 | 42,679 | 47,267 | |
17 |
673 | 8,586 | 16,201 | - | |
170/4 |
673 | 8,586 | 16,201 | - | |
42/48 |
82,093 | 71,006 | 26,478 | 47,267 | |
42 |
7,913 | 7,614 | 7,324 | - | |
44 |
5,342 | 336 | 3,335 | 41,228 | |
440/4 |
5,342 | 336 | 3,335 | 41,228 | |
45 |
15,817 | 5,304 | 2,452 | 3,224 | |
450/3 |
10,417 | 3,304 | 2,452 | 3,224 | |
454/9 |
5,400 | 2,000 | - | - | |
47/48 |
53,020 | 57,753 | 13,367 | 2,816 | |
492/3 |
1,100 | 3,632 | - | - | |
| Income statement | |||||
9900 |
81,731 | 57,163 | 54,854 | 12,010 | |
630 |
8,577 | 8,619 | 8,233 | 1,563 | |
640/8 |
501 | 98 | 154 | - | |
9901 |
72,653 | 48,447 | 46,467 | 10,447 | |
75/76B |
0 | - | - | - | |
75 |
0 | - | - | - | |
65/66B |
569 | 857 | 1,178 | 9 | |
65 |
569 | 857 | 1,178 | 9 | |
9903 |
72,084 | 47,590 | 45,288 | 10,438 | |
67/77 |
14,175 | 12,654 | 9,452 | 2,915 | |
9904 |
57,909 | 34,936 | 35,837 | 7,522 | |
9905 |
57,909 | 34,936 | 35,837 | 7,522 | |
| Appropriation of the result | |||||
9906 |
71,681 | 70,773 | 35,837 | 7,522 | |
14P |
13,773 | 35,837 | - | - | |
691/2 |
- | - | 0 | 7,522 | |
6921 |
- | - | 0 | 7,522 | |
694/7 |
71,681 | 57,000 | - | - | |
694 |
68,281 | 57,000 | - | - | |
695 |
3,400 | - | - | - | |
| Document | |||||
The full notes are in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 10-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankSubsidies and aid
Wallonia-Brussels Federation 2024, 1 entry, €67 in total
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible fixed assets | - | - | €2,730 | €39,794 |
| €8,577 | €8,619 | €8,233 | €1,563 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
Insights on DR ACKERMANS
The operating result for 2025 is 50% higher than in 2024 and the highest since 2023. It is the second rise in a row.
Debt's share of the balance-sheet total rises from 77.0% to 88.4%. Equity is lower and debt is higher.